Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) — Net Asset Quality Index
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) has a Net Asset Quality Index of 74.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥59.27 Billion minus total liabilities of CN¥15.02 Billion yields net assets of CN¥44.24 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Shenzhen Mindray Bio-Medical Electronics asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Net Asset Quality Index Over Time (2014–2024)
This chart shows how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 74.7%, representing net assets of CN¥44.24 Billion against total assets of CN¥59.27 Billion CNY. See Shenzhen Mindray Bio-Medical Electronics short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Shenzhen Mindray Bio-Medical Electronics market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 72.0% | CN¥40.76 Billion | CN¥56.64 Billion | CN¥15.89 Billion | ▲ +2.4 pp |
| 2023 | 69.6% | CN¥33.35 Billion | CN¥47.94 Billion | CN¥14.59 Billion | ▲ +1.1 pp |
| 2022 | 68.5% | CN¥32.00 Billion | CN¥46.75 Billion | CN¥14.75 Billion | ▼ -2.3 pp |
| 2021 | 70.8% | CN¥26.97 Billion | CN¥38.10 Billion | CN¥11.13 Billion | ▲ +0.8 pp |
| 2020 | 69.9% | CN¥23.29 Billion | CN¥33.31 Billion | CN¥10.02 Billion | ▼ -2.7 pp |
| 2019 | 72.6% | CN¥18.62 Billion | CN¥25.63 Billion | CN¥7.02 Billion | ▲ +2.4 pp |
| 2018 | 70.2% | CN¥15.18 Billion | CN¥21.63 Billion | CN¥6.45 Billion | ▲ +24.1 pp |
| 2017 | 46.1% | CN¥6.65 Billion | CN¥14.44 Billion | CN¥7.78 Billion | ▲ +10.6 pp |
| 2016 | 35.5% | CN¥4.60 Billion | CN¥12.97 Billion | CN¥8.37 Billion | ▼ -17.4 pp |
| 2015 | 52.9% | CN¥6.54 Billion | CN¥12.36 Billion | CN¥5.83 Billion | ▼ -13.4 pp |
| 2014 | 66.3% | CN¥9.66 Billion | CN¥14.58 Billion | CN¥4.92 Billion | — |